Synopsis
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Dl-amphetamine Sulfate
2. Amphetamine Sulphate
3. Phenaminum
4. 60-13-9
5. Amphamine Sulfate
6. Amphetamini Sulfas
7. Dl-phenamine Sulfate
8. Dl-amphetamine Sulphate
9. Amphetaminium Sulfuricum
10. Desoxynorephedrine Sulfate
11. (+-)-amphetamine Sulfate
12. Dl-amphetamine Hydrogen Sulfate
13. (+-)-phenisopropylamine Sulfate
14. Amfetamine Sulfate
15. Amphetamine Sulfate [usp]
16. Dl-1-phenyl-2-aminopropane Sulfate
17. (+-)-2-amino-1-phenylpropane Sulfate
18. (+-)-alpha-methylphenethylamine Sulfate (2:1)
19. 6dpv8nk46s
20. 1-phenylpropan-2-amine Sulfate (2:1)
21. Amphetamine Sulfate (usp)
22. Fenopromin Sulfate
23. Penamine (van)
24. Ccris 3644
25. 1-phenyl-2-aminopropane Sulfate
26. Cerm 1767
27. Razemisches Phenylaminopropansulfat
28. Dl-alpha-methylphenethylamine Sulfate
29. Einecs 200-457-8
30. Unii-6dpv8nk46s
31. Nsc 170999
32. Dl-amphetamine Sulfate Salt
33. Benzadrine
34. Alpha-methylphenethylamine Sulfate, (+-)-
35. Benzedrine (tn)
36. Evekeo (tn)
37. Evekeo Odt
38. Rac-amphetamine Sulphate
39. D-amphetamine Sulfate Salt
40. Schembl41204
41. Amphetamine Sulfate [mi]
42. Dtxsid4020082
43. Phenethylamine, Alpha-methyl-, Sulfate (2:1), (+-)-
44. Chebi:51063
45. Amfetamine Sulfate [mart.]
46. Amphetamine Sulfate [vandf]
47. Amfetamine Sulfate [who-dd]
48. Bis{1-phenylpropan-2-amine} Sulfate
49. Amfetamine Sulfate [ep Impurity]
50. Amfetamine Sulfate [ep Monograph]
51. Amphetamine Sulfate [orange Book]
52. .beta.-phenylisopyropylaminesulfate
53. Benzeneethanamine, Alpha-methyl-, Sulfate
54. Amphetamine Sulfate [usp Monograph]
55. Amfetamine Sulfate [incb:green List]
56. Delcobese Component Amphetamine Sulfate
57. D02074
58. (+/-)-2-amino-1-phenylpropane Sulfate
59. (+/-)-2-amino-1-phenylpropane Sulphate
60. Amphetamine Sulfate Component Of Delcobese
61. Q21270844
62. (+/-)-.alpha.-methylphenethylamine Sulfate (2:1)
63. (+/-)-.alpha.-methylphenethylamine Sulphate (2:1)
64. Benzeneethanamine, .alpha.-methyl-, Sulfate (2:1), (+/-)-
65. Benzeneethanamine, .alpha.-methyl-, Sulphate (2:1), (+/-)-
66. Dl-amphetamine Sulfate Salt Solution, Drug Standard, 1.0 Mg/ml In Methanol
67. 2-(tetrahydro-furan-2-yl)-n-(3-trifluoromethyl-phenyl)-succinamicacid
68. 156-31-0
1. Amfetamine
2. Mydrial
3. Desoxynorephedrine
4. L Amphetamine
Molecular Weight | 368.5 g/mol |
---|---|
Molecular Formula | C18H28N2O4S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 4 |
Exact Mass | 368.17697855 g/mol |
Monoisotopic Mass | 368.17697855 g/mol |
Topological Polar Surface Area | 135 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 166 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
About the Company : Veranova is a global leader in the development and manufacturing of specialist and complex APIs for pharma and biotech customers. We have over 50 years of experience navigating the...
About the Company : Axyntis Group, founded in 2007, is France’s leading independent multi-site player in fine chemicals with a €90 million annual turnover. Axyntis has become a key producer of API...
About the Company : Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. With over 35 years...
About the Company : Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. With over 35 years...
About the Company : Chr. Olesen Synthesis is a Danish manufacturer of APIs and advanced intermediates. Chr. Olesen Synthesis was established in 2012 after the Chr. Olesen Group acquisition of the mult...
About the Company : Curia is a global contract research, development and manufacturing organization (CDMO), offering products and services across the drug development spectrum to help our partners tur...
About the Company : We have been supporting the pharmaceutical and biopharmaceutical industries with drug development for over 30 years, assisting our clients in developing and bringing new drugs to m...
About the Company : We have been supporting the pharmaceutical and biopharmaceutical industries with drug development for over 30 years, assisting our clients in developing and bringing new drugs to m...
About the Company : Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to addr...
About the Company : Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to addr...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Dextroamphetamine Sulfate is a non-catecholamine sympathomimetic amines with CNS stimulant activity. It is thought to block the reuptake of norepinephrine and dopamine into the presynaptic neuron and increase the release of these monoamines into the extraneuronal space.
Lead Product(s): Amphetamine,Dextroamphetamine Saccharate,Amphetamine Aspartate
Therapeutic Area: Psychiatry/Psychology Brand Name: Amphetamine-Generic
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 24, 2023
Lead Product(s) : Amphetamine,Dextroamphetamine Saccharate,Amphetamine Aspartate
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Granules Pharmaceuticals Inc., Receives ANDA Approval for Amphetamine Mixed Salts ER Capsules
Details : Dextroamphetamine Sulfate is a non-catecholamine sympathomimetic amines with CNS stimulant activity. It is thought to block the reuptake of norepinephrine and dopamine into the presynaptic neuron and increase the release of these monoamines into the extr...
Brand Name : Amphetamine-Generic
Molecule Type : Small molecule
Upfront Cash : Not Applicable
January 24, 2023
Details:
FDA approved generic of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, for Attention Deficit Hyperactivity Disorder and Narcolepsy.
Lead Product(s): Dextroamphetamine Saccharate,Amphetamine Aspartate,Amphetamine
Therapeutic Area: Psychiatry/Psychology Brand Name: Adderall-Generic
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable December 30, 2021
Lead Product(s) : Dextroamphetamine Saccharate,Amphetamine Aspartate,Amphetamine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Granules Pharmaceuticals Receives ANDA Approval for Amphetamine Mixed Salts (IR Tablets)
Details : FDA approved generic of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, for Attention Deficit Hyperactivity Disorder and Narcolepsy.
Brand Name : Adderall-Generic
Molecule Type : Small molecule
Upfront Cash : Not Applicable
December 30, 2021
Details:
Adderall XR-Generic is a combination product of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate & amphetamine sulfate. It is indicated for ADHD.
Lead Product(s): Dextroamphetamine Saccharate,Amphetamine Aspartate,Amphetamine
Therapeutic Area: Psychiatry/Psychology Brand Name: Adderall XR-Generic
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable November 21, 2024
Lead Product(s) : Dextroamphetamine Saccharate,Amphetamine Aspartate,Amphetamine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lupin Receives FDA Approval for Generic Version of Adderall XR
Details : Adderall XR-Generic is a combination product of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate & amphetamine sulfate. It is indicated for ADHD.
Brand Name : Adderall XR-Generic
Molecule Type : Small molecule
Upfront Cash : Not Applicable
November 21, 2024
Details:
The agreement aims for the distribution and supply for Aytu's Adzenys XR-ODT and Cotempla XR-ODT product lines for the treatment of ADHD in Canada.
Lead Product(s): Amphetamine
Therapeutic Area: Psychiatry/Psychology Brand Name: Adzenys XR-ODT
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Lupin Pharma Canada
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement October 01, 2024
Lead Product(s) : Amphetamine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Lupin Pharma Canada
Deal Size : Undisclosed
Deal Type : Agreement
Aytu BioPharma Partners with Lupin Canada For ADHD Drug Commercialization
Details : The agreement aims for the distribution and supply for Aytu's Adzenys XR-ODT and Cotempla XR-ODT product lines for the treatment of ADHD in Canada.
Brand Name : Adzenys XR-ODT
Molecule Type : Small molecule
Upfront Cash : Undisclosed
October 01, 2024
Details:
Tris Pharma and Perigon launched a direct-to-patient program, that allows patients and caregivers access to DYANAVEL XR (amphetamine) extended-release tablets through Perigon’s digital pharmacy and receive assistance and support to help navigate their treatment journey.
Lead Product(s): Amphetamine
Therapeutic Area: Psychiatry/Psychology Brand Name: Dyanavel XR
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Perigon Pharmacy 360
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership October 30, 2023
Lead Product(s) : Amphetamine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Perigon Pharmacy 360
Deal Size : Undisclosed
Deal Type : Partnership
Tris Pharma Partners with Perigon Pharmacy 360 to Enhance Access to DYANAVEL® XR Tablets for the ...
Details : Tris Pharma and Perigon launched a direct-to-patient program, that allows patients and caregivers access to DYANAVEL XR (amphetamine) extended-release tablets through Perigon’s digital pharmacy and receive assistance and support to help navigate their ...
Brand Name : Dyanavel XR
Molecule Type : Small molecule
Upfront Cash : Undisclosed
October 30, 2023
Details:
Under the agreement, Aardvark will acquire certain assets and intellectual property of the Company that pertain to ADAIR, a proprietary abuse-deterrent formulation of immediate release dextroamphetamine, for the development of certain follow-on pipeline programs.
Lead Product(s): Amphetamine
Therapeutic Area: Psychiatry/Psychology Brand Name: ADAIR
Study Phase: Phase IProduct Type: Small molecule
Sponsor: Aardvark Therapeutics
Deal Size: $80.0 million Upfront Cash: Undisclosed
Deal Type: Agreement August 23, 2023
Lead Product(s) : Amphetamine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Aardvark Therapeutics
Deal Size : $80.0 million
Deal Type : Agreement
Details : Under the agreement, Aardvark will acquire certain assets and intellectual property of the Company that pertain to ADAIR, a proprietary abuse-deterrent formulation of immediate release dextroamphetamine, for the development of certain follow-on pipeline ...
Brand Name : ADAIR
Molecule Type : Small molecule
Upfront Cash : Undisclosed
August 23, 2023
Details:
Under the agreement, Medomie will commercialize Adzenys XR-ODT (amphetamine) and Cotempla XR-ODT (methylphenidate) in Israel and the Palestinian Authority.
Lead Product(s): Amphetamine
Therapeutic Area: Psychiatry/Psychology Brand Name: Adzenys XR
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Aytu BioPharma
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement July 31, 2023
Lead Product(s) : Amphetamine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Aytu BioPharma
Deal Size : Undisclosed
Deal Type : Agreement
Details : Under the agreement, Medomie will commercialize Adzenys XR-ODT (amphetamine) and Cotempla XR-ODT (methylphenidate) in Israel and the Palestinian Authority.
Brand Name : Adzenys XR
Molecule Type : Small molecule
Upfront Cash : Undisclosed
July 31, 2023
Details:
Under the agreement, Glenmark will distribute Cediprof's FDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product), the generic version of Adderall® Tablets.
Lead Product(s): Dextroamphetamine Saccharate,Amphetamine Aspartate,Amphetamine
Therapeutic Area: Psychiatry/Psychology Brand Name: Adderall-Generic
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Cediprof
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement March 09, 2023
Lead Product(s) : Dextroamphetamine Saccharate,Amphetamine Aspartate,Amphetamine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Cediprof
Deal Size : Undisclosed
Deal Type : Agreement
Details : Under the agreement, Glenmark will distribute Cediprof's FDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product), the generic version...
Brand Name : Adderall-Generic
Molecule Type : Small molecule
Upfront Cash : Undisclosed
March 09, 2023
Details:
Xelstrym™ (dextroamphetamine) is a first and only FDA-approved, once-daily central nervous system stimulant transdermal patch for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older.
Lead Product(s): Amphetamine
Therapeutic Area: Psychiatry/Psychology Brand Name: Xelstrym
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 10, 2023
Lead Product(s) : Amphetamine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
XELSTRYM™ (dextroamphetamine) transdermal system, CII, to be revealed as available soon at the 2...
Details : Xelstrym™ (dextroamphetamine) is a first and only FDA-approved, once-daily central nervous system stimulant transdermal patch for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older.
Brand Name : Xelstrym
Molecule Type : Small molecule
Upfront Cash : Not Applicable
January 10, 2023
Details:
Dyanavel XR oral suspension (amphetamine) is a CNS stimulant that affects chemicals in the brain and nerves that contribute to hyperactivity and impulse control used for the treatment of attention deficit hyperactivity disorder (ADHD) in people 6 years and older.
Lead Product(s): Amphetamine
Therapeutic Area: Psychiatry/Psychology Brand Name: Dyanavel XR
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Pediatrix Therapeutics
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership December 01, 2022
Lead Product(s) : Amphetamine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Pediatrix Therapeutics
Deal Size : Undisclosed
Deal Type : Partnership
Details : Dyanavel XR oral suspension (amphetamine) is a CNS stimulant that affects chemicals in the brain and nerves that contribute to hyperactivity and impulse control used for the treatment of attention deficit hyperactivity disorder (ADHD) in people 6 years a...
Brand Name : Dyanavel XR
Molecule Type : Small molecule
Upfront Cash : Undisclosed
December 01, 2022
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Brand Name : DEXTROAMPHETAMINE
Dosage Form : TABLET
Dosage Strength : 5MG
Packaging : 100/500
Approval Date :
Application Number : 2443236
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Brand Name : TEVA-DEXTROAMPHETAMINE SR
Dosage Form : CAPSULE (SUSTAINED-RELEASE)
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number : 2448319
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Brand Name : TEVA-DEXTROAMPHETAMINE SR
Dosage Form : CAPSULE (SUSTAINED-RELEASE)
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number : 2448327
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Brand Name : DEXEDRINE
Dosage Form : TABLET
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 1924516
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Brand Name : DEXEDRINE SPANSULE
Dosage Form : CAPSULE (SUSTAINED-RELEASE)
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number : 1924567
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Brand Name : DEXEDRINE SPANSULE
Dosage Form : CAPSULE (SUSTAINED-RELEASE)
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number : 1924559
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 5MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 10MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 15MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : U.S.A
Brand Name : Adderall
Dosage Form : Tablet
Dosage Strength : 7.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 7.5MG
Brand Name : Adderall
Approval Date :
Application Number :
Registration Country : U.S.A
Regulatory Info :
Registration Country : U.S.A
Brand Name : Adderall
Dosage Form : Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 10MG
Brand Name : Adderall
Approval Date :
Application Number :
Registration Country : U.S.A
Regulatory Info :
Registration Country : U.S.A
Brand Name : Adderall
Dosage Form : Tablet
Dosage Strength : 12.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 12.5MG
Brand Name : Adderall
Approval Date :
Application Number :
Registration Country : U.S.A
Regulatory Info :
Registration Country : U.S.A
Amphetamine; Dextroamphetamine
Brand Name :
Dosage Form : Tablet
Dosage Strength :
Packaging : Size: 100s
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Packaging : Size: 100s
Regulatory Info :
Amphetamine; Dextroamphetamine
Dosage : Tablet
Dosage Strength :
Brand Name :
Approval Date :
Application Number :
Registration Country : U.S.A
Regulatory Info :
Registration Country : U.S.A
Amphetamine; Dextroamphetamine
Brand Name :
Dosage Form : Tablet
Dosage Strength :
Packaging : Size: 100s
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Packaging : Size: 100s
Regulatory Info :
Amphetamine; Dextroamphetamine
Dosage : Tablet
Dosage Strength :
Brand Name :
Approval Date :
Application Number :
Registration Country : U.S.A
Regulatory Info :
Registration Country : U.S.A
Brand Name :
Dosage Form : Extended Release Capsu...
Dosage Strength : 5MG
Packaging : Size: 100s
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Packaging : Size: 100s
Regulatory Info :
Dosage : Extended Release Capsu...
Dosage Strength : 5MG
Brand Name :
Approval Date :
Application Number :
Registration Country : U.S.A
Regulatory Info :
Registration Country : U.S.A
Brand Name :
Dosage Form : Extended Release Capsu...
Dosage Strength : 10MG
Packaging : Size: 100s
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Packaging : Size: 100s
Regulatory Info :
Dosage : Extended Release Capsu...
Dosage Strength : 10MG
Brand Name :
Approval Date :
Application Number :
Registration Country : U.S.A
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Tablet
Grade : Not Available
Application : Controlled & Modified Release
Excipient Details : Solubilization, dispersion, crystallization inhibition, instant release matrices & spray drying
Dosage Form : Tablet
Grade : Not Available
Application : Solubilizers
Excipient Details : Solubilization, dispersion, crystallization inhibition, instant release matrices & spray drying
Pharmacopoeia Ref : Ph. Eur., USP, JP: Povidone
Technical Specs : Not Available
Ingredient(s) : Povidone
Dosage Form : Capsule
Grade : Not Available
Application : Fillers, Diluents & Binders
Excipient Details : Tablet binding, thickener, stabilizers of suspensions, reduces sedimentation, crystallization inhibition.
Pharmacopoeia Ref : Ph. Eur., USP, JP: Povidone
Technical Specs : Not Available
Ingredient(s) : Povidone
Dosage Form : Granule / Pellet
Grade : Not Available
Application : Disintegrants & Superdisintegrants
Excipient Details : Maximum disintegration
Pharmacopoeia Ref : Ph. Eur., USP, JP: Crospovidon...
Technical Specs : Not Available
Ingredient(s) : Polyvinylpyrrolidone Crosslinked
Dosage Form : Capsule
Grade : Not Available
Application : Disintegrants & Superdisintegrants
Excipient Details : Kollidon CL-F has a balance of strong disintegration and optimal surface homogeneity.
Pharmacopoeia Ref : Ph. Eur., USP, JP: Crospovidon...
Technical Specs : Not Available
Ingredient(s) : Polyvinylpyrrolidone Crosslinked
Dosage Form : Tablet
Grade : Not Available
Application : Granulation
Excipient Details : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.
Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 %...
Technical Specs : Not Available
Ingredient(s) : Povidone
Dosage Form : Tablet
Grade : Not Available
Application : Film Formers & Plasticizers
Excipient Details : Liquid plasticizer with high ADI, hydrophilic solvent & humectant in emulsions, skin penetration enhancer in topical formulaitons.
Pharmacopoeia Ref : Ph. Eur., JP, FCC, USP
Technical Specs : Not Available
Ingredient(s) : Propylene Glycol
Dosage Form : Softgel Capsule
Grade : Not Available
Application : Thickeners and Stabilizers
Excipient Details : Structure-building consistency factor with dry feel, forms crystalline barrier on skin
Pharmacopoeia Ref : Ph. Eur., USP-NF, JP: Stearic ...
Technical Specs : Not Available
Ingredient(s) : Stearic Acid
Dosage Form : Orodispersible Tablet
Grade : Not Available
Application : Chewable & Orodispersible Aids
Excipient Details : Ludiflash is a ready-to-use orally disintegrating tablet (ODT) solution with superior mouthfeel.
Pharmacopoeia Ref : Ph. Eur., USP, JP: 90 % mannit...
Technical Specs : Not Available
Ingredient(s) : Crospovidone
Dosage Form : Tablet
Grade : Not Available
Application : Granulation
Excipient Details : Ready-to-use direct compression solution for tablets.
Pharmacopoeia Ref : Ph.Eur., USP/NF and JP
Technical Specs : Not Available
Ingredient(s) : Crospovidone
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?